跳至主要内容
临床试验/CTIS2024-510892-40-00
CTIS2024-510892-40-00进行中(未招募)1 期

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients with Cardiogenic Shock from Acute Myocardial Infarction - NORshock

Amsterdam UMC0 个研究点目标入组 776 人开始时间: 2024年1月16日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
776

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Acute myocardial infarction, STEMI or NSTEMI, Early revascularization by PCI, Cardiogenic shock, characterized by: I. a. Systolic blood pressure (SBP) < 90 mmHg for > 30 minutes, OR b. Use of drugs to maintain SBP > 90 mmHg at presentation before randomization. II. Clinical signs of impaired organ perfusion with at least one of the following criteria: a. Altered mental status b. Cold, clammy skin and extremities c. Oliguria with urine output < 30ml/hour d. Serum lactate > 2.0 mmol/L III. Clinical signs of pulmonary congestion

排除标准

  • Resuscitation > 30 minutes, Mechanical cause of cardiogenic shock (e.g. papillary muscle rupture, ventricular septal rupture), Onset of shock > 12 hours, Imminent need for mechanical circulatory support, Women < 45 years

研究者

发起方
Amsterdam UMC

相似试验